Michael J. Donovan MD, PhD

Dr. Michael J. Donovan, PhD, MD is a board certified anatomic and clinical pathologist with subspecialty boards in pediatric pathology. In addition to an academic career at Harvard Medical School and Boston Childrens Hospital, Dr. Donovan was in the biotechnology space for over 15 years and has worked with a variety of companies including Millennium Pharmaceuticals, Genentech, Incyte and most recently served as the Chief Scientific Officer for Aureon Biosciences and the Chief Medical Officer of Exosome Dx. He has spear-headed the utilization of multiplex tissue and fluid-based assays and coupled mathematic applications to produce clinically relevant diagnostic/predictive/prognostic outcome models for a variety of tumor types and disease states. Dr. Donovan is currently the Director of the Biorepository at Sinai and is the Director of the Experimental Pathology program across Mt. Sinai.